REAL-WORLD BIOLOGIC USE AND SWITCHING AMONG ADULTS WITH SEVERE ASTHMA TREATED BY US SUBSPECIALISTS IN THE CHRONICLE STUDY

被引：0
|
作者：
Panettieri, Reynold A.
Ledford, Dennis K.
Chipps, Bradley E.
Soong, Weily
Lugogo, Njira L.
Mohan, Arjun
Carstens, Donna D.
Genofre, Eduardo H.
Trudo, Frank
Ambrose, Christopher
机构：
来源：
CHEST | 2022年 / 162卷 / 04期
关键词：
D O I：
10.1016/j.chest.2022.08.2241
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：2709A / 2714A
页数：6
相关论文
共 50 条
  • [21] Factors Associated with Asthma Hospitalization Among US Adults with Severe Asthma Enrolled in the CHRONICLE Study
    Trevor, J.
    Panettieri, R. A.
    Lugogo, N.
    Soong, W.
    Belton, L.
    Trudo, F.
    Ambrose, C. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [22] A real-world study of inhaled corticosteroid use in patients with severe eosinophilic asthma treated with mepolizumab
    Corren, Jonathan
    Silver, Jared
    Molfino, Nestor A.
    Bogart, Michael
    Packnett, Elizabeth
    McMorrow, Donna
    Wu, Juan
    Hahn, Beth
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 128 (02) : 184 - +
  • [23] BIOLOGIC OUTCOMES AMONG ADULTS WITH SEVERE ASTHMA BY AGE OF ONSET: RESULTS: FROM CHRONICLE
    Ledford, D.
    Carr, W.
    Moore, W.
    Lugogo, N.
    Mohan, A.
    Lindsley, A.
    Spahn, J.
    Ambrose, C.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S48 - S48
  • [24] Characterizing Real-World Use of LAMAs in Asthma in the US
    Averell, C. M.
    Laliberte, F.
    Duh, M.
    Wu, J. W.
    Germain, G.
    Katial, R.
    Faison, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [25] Adverse consequences of systemic corticosteroids use among a broad population of US adults with asthma: a real-world analysis
    Wu, Sandra Sze-jung
    Vu, Michelle
    Motawakel, Omar
    Bancroft, Tim
    Johnson, Karen
    Song, Rui
    Veeranki, Phani
    Lanz, Miguel J.
    JOURNAL OF MEDICAL ECONOMICS, 2025, 28 (01) : 413 - 424
  • [26] Real-world clinical remission of severe asthma with benralizumab in Spanish adults with severe asthma
    Martinez-Moragon, Eva
    Chiner, Eusebi
    Mogrovejo, Alexandra Suliana
    Cervera, Marta Palop
    Tortajada, Inmaculada Lluch
    Enrique, Ignacio Boira
    Vera, Andres Fernando Sanchez
    JOURNAL OF ASTHMA, 2024, 61 (10) : 1190 - 1204
  • [27] TEZEPELUMAB IS EFFECTIVE IN REDUCING EXACERBATIONS AFTER BIOLOGIC SWITCHING: REAL-WORLD EXPERIENCE IN A COHORT OF IN SEVERE ASTHMA PATIENTS
    Bagheri, Amirbehzad
    Senn, Rebecca
    Harwood, Hannah
    Derstine, Brian
    Mohan, Arjun
    Lugogo, Njira L.
    CHEST, 2023, 164 (04) : 63A - 66A
  • [28] MORTALITY AMONG ADULTS WITH SUBSPECIALIST-TREATED SEVERE ASTHMA: RESULTS FROM THE CHRONICLE STUDY
    Lugogo, Njira L.
    Trevor, Jennifer L.
    Spahn, Joe D.
    Panettieri, Reynold A.
    Carstens, Donna D.
    Ambrose, Christopher
    CHEST, 2023, 164 (04) : 18A - 22A
  • [29] The CHRONICLE Study of US Adults with Subspecialist-Treated Severe Asthma: Objectives, Design, and Initial Results
    Ambrose, Christopher S.
    Chipps, Bradley E.
    Moore, Wendy C.
    Soong, Weily
    Trevor, Jennifer
    Ledford, Dennis K.
    Carr, Warner W.
    Lugogo, Njira
    Trudo, Frank
    Tran, Trung N.
    Panettieri, Reynold A., Jr.
    PRAGMATIC AND OBSERVATIONAL RESEARCH, 2020, 11 : 77 - 90
  • [30] Benralizumab effectiveness in patients with severe asthma regardless of prior biologic use: A real-world Canadian experience
    Nair, Parameswaran
    Kayaniyil, Sheena
    St Pierre, Charles
    Osenenko, Katherine
    Li, Tina
    Johnston, Karissa
    Lacuesta, Gina
    Khan, Irfan
    Anees, Syed
    Lai, Yew Hon
    Rahimi, Parisa
    Dhawan, Vivek
    Dorscheid, Delbert
    Cote, Andreanne
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
12345